Polyrizon ltd.PLRZ.US Overview

US StockHealthcare

(No presentation for PLRZ)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

PLRZ Overall Performance

PLRZ AI Analysis & Strategy

PLRZ Recent Performance

-0.45%

Polyrizon ltd.

0.81%

Avg of Sector

-1.14%

S&P500

PLRZ PowerScanner

PLRZ Key Information

PLRZ Valuation Metrics

PLRZ Earnings Table

PLRZ Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.